FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1958379738> ?p ?o ?g. }

• W1958379738 abstract "Bronchopulmonary dysplasia (BPD), defined as oxygen dependence at 36 weeks postmenstrual age (PMA), remains an important complication of prematurity. Pulmonary inflammation plays a central role in the pathogenesis of BPD. Attenuating pulmonary inflammation with postnatal systemic corticosteroids reduces the incidence of BPD in preterm infants but may be associated with an increased risk of adverse neurodevelopmental outcomes. Local administration of corticosteroids via inhalation might be an effective and safe alternative.To determine if administration of inhalation corticosteroids after the first week of life until 36 weeks PMA to preterm infants at high risk of developing BPD is effective and safe in reducing the incidence of death and BPD as separate or combined outcomes.We used the standard search strategy of Cochrane Neonatal to search the Cochrane Central Register of Controlled Trials (CENTRAL 2017, Issue 4), MEDLINE via PubMed (1966 to 19 May 2017), Embase (1980 to 19 May 2017), and CINAHL (1982 to 19 May 2017). We also searched clinical trials databases, conference proceedings, and the reference lists of retrieved articles for randomised controlled trials and quasi-randomised trials.We included randomised controlled trials comparing inhalation corticosteroids, started ≥ 7 days postnatal age (PNA) but before 36 weeks PMA, to placebo in ventilated and non-ventilated infants at risk of BPD. We excluded trials investigating systemic corticosteroids versus inhalation corticosteroids.We collected data on participant characteristics, trial methodology, and inhalation regimens. The primary outcome was death or BPD at 36 weeks PMA. Secondary outcomes were the combined outcome death or BPD at 28 days PNA, the seperate outcomes of death and BPD at both 28 days PNA, and at 36 weeks PMA, and short-term respiratory outcomes, such as failure to extubate; total days of mechanical ventilation and oxygen use; and the need for systemic corticosteroids. We contacted the original trialists to verify the validity of extracted data and to provide missing data. We analysed all data using Review Manager 5. When possible, we performed meta-analysis using typical risk ratio (RR) for dichotomous outcomes and weighted mean difference (WMD) for continuous outcomes along with their 95% confidence intervals (CI). We analysed ventilated and non-ventilated participants separately.We used the GRADE approach to assess the quality of the evidence.We included eight trials randomising 232 preterm infants in this review. Inhalation corticosteroids did not reduce the separate or combined outcomes of death or BPD. The meta-analyses of the studies showed a reduced risk in favor of inhalation steroids regarding failure to extubate at seven days (typical RR (TRR) 0.80, 95% CI 0.66 to 0.98; 5 studies, 79 infants) and at the latest reported time point after treatment onset (TRR 0.60, 95% CI 0.45 to 0.80; 6 studies, 90 infants). However, both analyses showed increased statistical heterogeneity (I2 statistic 73% and 86%, respectively). Furthermore, inhalation steroids did not impact total duration of mechanical ventilation or oxygen dependency. There was a trend toward a reduction in the use of systemic corticosteroids in infants receiving inhalation corticosteroids (TRR 0.51, 95% CI 0.26 to 1.00; 4 studies, 74 infants; very low-quality evidence). There was a paucity of data on short- and long-term adverse effects. Our results should be interpreted with caution because the total number of randomised participants is relatively small, and most trials differed considerably in participant characteristics, inhalation therapy, and outcome definitions.Based on the results of the currently available evidence, inhalation corticosteroids initiated at ≥ 7 days of life for preterm infants at high risk of developing BPD cannot be recommended at this point in time. More and larger randomised, placebo-controlled trials are needed to establish the efficacy and safety of inhalation corticosteroids." @default.
• W1958379738 created "2016-06-24" @default.
• W1958379738 creator A5015206545 @default.
• W1958379738 creator A5032751353 @default.
• W1958379738 creator A5071987242 @default.
• W1958379738 date "2017-08-24" @default.
• W1958379738 modified "2023-09-23" @default.
• W1958379738 title "Late (≥ 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants" @default.
• W1958379738 cites W14524605 @default.
• W1958379738 cites W1492259718 @default.
• W1958379738 cites W1529534179 @default.
• W1958379738 cites W1620361783 @default.
• W1958379738 cites W1641161373 @default.
• W1958379738 cites W1748818404 @default.
• W1958379738 cites W1818661018 @default.
• W1958379738 cites W1862088640 @default.
• W1958379738 cites W1892766975 @default.
• W1958379738 cites W1911366939 @default.
• W1958379738 cites W1911489868 @default.
• W1958379738 cites W1955646544 @default.
• W1958379738 cites W1958379738 @default.
• W1958379738 cites W1967505834 @default.
• W1958379738 cites W1974794798 @default.
• W1958379738 cites W1979182123 @default.
• W1958379738 cites W1983811027 @default.
• W1958379738 cites W1984825177 @default.
• W1958379738 cites W1986157685 @default.
• W1958379738 cites W1986908751 @default.
• W1958379738 cites W1987663932 @default.
• W1958379738 cites W1988676681 @default.
• W1958379738 cites W2001327322 @default.
• W1958379738 cites W2008343121 @default.
• W1958379738 cites W2014549335 @default.
• W1958379738 cites W2016686337 @default.
• W1958379738 cites W2017696050 @default.
• W1958379738 cites W2024082505 @default.
• W1958379738 cites W2024305149 @default.
• W1958379738 cites W2025092534 @default.
• W1958379738 cites W2027502927 @default.
• W1958379738 cites W2037543939 @default.
• W1958379738 cites W2041263675 @default.
• W1958379738 cites W2044240873 @default.
• W1958379738 cites W2045328533 @default.
• W1958379738 cites W2048714173 @default.
• W1958379738 cites W2050932527 @default.
• W1958379738 cites W2055208024 @default.
• W1958379738 cites W2055246522 @default.
• W1958379738 cites W2059746880 @default.
• W1958379738 cites W2064955522 @default.
• W1958379738 cites W2069038664 @default.
• W1958379738 cites W2081066848 @default.
• W1958379738 cites W2081106233 @default.
• W1958379738 cites W2082130591 @default.
• W1958379738 cites W2082323195 @default.
• W1958379738 cites W2083354864 @default.
• W1958379738 cites W2090594538 @default.
• W1958379738 cites W2093442618 @default.
• W1958379738 cites W2102806222 @default.
• W1958379738 cites W2106491684 @default.
• W1958379738 cites W2119881240 @default.
• W1958379738 cites W2125327493 @default.
• W1958379738 cites W2150926002 @default.
• W1958379738 cites W2155900431 @default.
• W1958379738 cites W2163092709 @default.
• W1958379738 cites W2171593131 @default.
• W1958379738 cites W2314661573 @default.
• W1958379738 cites W2531739243 @default.
• W1958379738 cites W2587062801 @default.
• W1958379738 cites W4235129791 @default.
• W1958379738 cites W4236703420 @default.
• W1958379738 cites W4239402313 @default.
• W1958379738 cites W4247347483 @default.
• W1958379738 cites W4248251600 @default.
• W1958379738 cites W4252353908 @default.
• W1958379738 cites W4321319148 @default.
• W1958379738 doi "https://doi.org/10.1002/14651858.cd002311.pub4" @default.
• W1958379738 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6483527" @default.
• W1958379738 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28836266" @default.
• W1958379738 hasPublicationYear "2017" @default.
• W1958379738 type Work @default.
• W1958379738 sameAs 1958379738 @default.
• W1958379738 citedByCount "47" @default.
• W1958379738 countsByYear W19583797382013 @default.
• W1958379738 countsByYear W19583797382014 @default.
• W1958379738 countsByYear W19583797382015 @default.
• W1958379738 countsByYear W19583797382016 @default.
• W1958379738 countsByYear W19583797382017 @default.
• W1958379738 countsByYear W19583797382018 @default.
• W1958379738 countsByYear W19583797382019 @default.
• W1958379738 countsByYear W19583797382021 @default.
• W1958379738 countsByYear W19583797382022 @default.
• W1958379738 countsByYear W19583797382023 @default.
• W1958379738 crossrefType "journal-article" @default.
• W1958379738 hasAuthorship W1958379738A5015206545 @default.
• W1958379738 hasAuthorship W1958379738A5032751353 @default.
• W1958379738 hasAuthorship W1958379738A5071987242 @default.
• W1958379738 hasBestOaLocation W19583797382 @default.
• W1958379738 hasConcept C120665830 @default.
• W1958379738 hasConcept C121332964 @default.
• W1958379738 hasConcept C126322002 @default.

• next